Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to -$8.8 billion.

  • Legend Biotech's Change in Acquisitions & Divestments fell 15649.39% to -$8.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 billion, marking a year-over-year decrease of 916153.28%. This contributed to the annual value of $483.6 million for FY2022, which is 16867.61% up from last year.
  • As of Q3 2025, Legend Biotech's Change in Acquisitions & Divestments stood at -$8.8 billion, which was down 15649.39% from $3.9 billion recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Change in Acquisitions & Divestments peaked at $3.9 billion during Q2 2025, and registered a low of -$8.8 billion during Q3 2025.
  • In the last 5 years, Legend Biotech's Change in Acquisitions & Divestments had a median value of $180.0 million in 2021 and averaged -$175.3 million.
  • In the last 5 years, Legend Biotech's Change in Acquisitions & Divestments surged by 112582.43% in 2023 and then plummeted by 24699.79% in 2024.
  • Over the past 5 years, Legend Biotech's Change in Acquisitions & Divestments (Quarter) stood at $180.0 million in 2021, then soared by 168.68% to $483.6 million in 2022, then soared by 383.23% to $2.3 billion in 2023, then tumbled by 247.0% to -$3.4 billion in 2024, then plummeted by 156.49% to -$8.8 billion in 2025.
  • Its last three reported values are -$8.8 billion in Q3 2025, $3.9 billion for Q2 2025, and $374.0 million during Q1 2025.